BICO Group's earnings have been declining at an average annual rate of -48.1%, while the Life Sciences industry saw earnings declining at 3.5% annually. Revenues have been growing at an average rate of 4.8% per year.
Key information
-48.05%
Earnings growth rate
-44.81%
EPS growth rate
Life Sciences Industry Growth
21.51%
Revenue growth rate
4.83%
Return on equity
-91.98%
Net Margin
-98.95%
Next Earnings Update
19 Aug 2026
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How BICO Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
OTCPK:CLLK.F Revenue, expenses and earnings (SEK Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
31 Mar 26
1,492
-1,477
833
202
31 Dec 25
1,497
-1,580
828
205
30 Sep 25
1,561
-1,270
882
110
30 Jun 25
1,543
-424
896
110
31 Mar 25
1,642
-323
901
131
31 Dec 24
1,727
-107
911
228
30 Sep 24
1,609
-803
874
364
30 Jun 24
1,828
-583
904
424
31 Mar 24
1,941
-729
967
425
31 Dec 23
2,010
-788
986
343
30 Sep 23
2,213
-497
1,140
253
30 Jun 23
2,256
-390
1,380
143
31 Mar 23
2,297
-117
1,645
67
31 Dec 22
2,327
-85
1,818
0
30 Sep 22
2,278
41
1,857
0
30 Jun 22
1,995
-130
1,666
0
31 Mar 22
1,743
-224
1,354
0
31 Dec 21
1,378
-228
1,061
0
30 Sep 21
993
-188
749
0
30 Jun 21
744
-96
519
0
31 Mar 21
460
-50
342
0
31 Dec 20
369
-36
273
0
31 Aug 20
236
-62
218
0
31 May 20
213
-49
197
0
29 Feb 20
197
-24
176
0
30 Nov 19
173
-5
138
0
31 Aug 19
135
1
106
0
31 May 19
118
3
87
0
28 Feb 19
97
4
69
0
30 Nov 18
76
2
55
0
31 Aug 18
61
1
43
0
31 May 18
45
1
30
0
28 Feb 18
34
-2
24
0
30 Nov 17
27
-2
21
0
31 Aug 17
20
-1
16
0
31 Aug 16
6
-1
4
0
Quality Earnings: CLLK.F is currently unprofitable.
Growing Profit Margin: CLLK.F is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CLLK.F is unprofitable, and losses have increased over the past 5 years at a rate of 48.1% per year.
Accelerating Growth: Unable to compare CLLK.F's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: CLLK.F is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (5.2%).
Return on Equity
High ROE: CLLK.F has a negative Return on Equity (-91.98%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/06/22 06:30
End of Day Share Price
2026/06/12 00:00
Earnings
2026/03/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
BICO Group AB (publ) is covered by 3 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.